https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
240
 
downloads
73
CITE
How to cite this poster:
Szer J, Muus P, Röth A et al. Long-term safety of sustained eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria. F1000Posters 2013, 4:211 (poster)

Long-term safety of sustained eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria

Jeffrey Szer1, Petra Muus, Alexander Röth, Modupe O Elebute, Antonio M Risitano, Hubert Schrezenmeier, Jaroslaw P Maciejewski, Alvaro Urbano-Ispizua, Carlos de Castro, Gérard Socié, Robert A Brodsky
Published 02 May 2013
Author Affiliations
  • Metrics
  • 240 Views
  • 73 Downloads
Browse by related subjects
Published 02 May 2013

Long-term safety of sustained eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria

[version 1; not peer reviewed]

Jeffrey Szer1, Petra Muus, Alexander Röth, Modupe O Elebute, Antonio M Risitano, Hubert Schrezenmeier, Jaroslaw P Maciejewski, Alvaro Urbano-Ispizua, Carlos de Castro, Gérard Socié, Robert A Brodsky
Author Affiliations
1 Royal Melbourne Hospital, Australia
Presented at
54th American Society of Hematology Annual Meeting 2012
Abstract
Competing Interests

Drs Muus and Urbano-Ispizua have sat on an advisory board for Alexion Pharmaceuticals. Dr Roth has received honoraria and research funding from Alexion Pharmaceuticals. Dr Elebute has received honoraria from and sat on an advisory board for Alexion Pharmaceuticals. Dr Risitano has received research funding from and sat on an advisory board for Alexion Pharmaceuticals. Dr Maciejewski has received research funding from the NIH and the Aplastic Anemia and MDS International Foundation. Dr de Castro has served on a speakers' bureau for Alexion Pharmaceuticals. Drs Szer, Schrezenmeier, Socie, and Brodsky have nothing to disclose.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.